共 50 条
- [1] Resistance to First-line Osimertinib in EGFR-mutant NSCLC: Tissue is the Issue[J]. CLINICAL CANCER RESEARCH, 2020, 26 (11) : 2441 - 2443Piotrowska, Zofia论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USAHata, Aaron N.论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
- [2] CNS Control after First-Line Osimertinib in Patients with Metastatic EGFR-Mutant NSCLC[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E110 - E110Hui, C.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USAWakelee, H. A.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USANeal, J. W.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USARamchandran, K. J.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Palo Alto, CA USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USADas, M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USANagpal, S.论文数: 0 引用数: 0 h-index: 0机构: Stanford Canc Inst, Dept Neurol, Stanford, CA USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USARoy, M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USAHuang, J.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USAPollom, E.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USAMyall, N.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
- [3] Safety of tepotinib plus osimertinib in EGFR-mutant NSCLC with MET amplification after first-line osimertinib[J]. ANNALS OF ONCOLOGY, 2023, 34 : S1691 - S1691Liam, C. K.论文数: 0 引用数: 0 h-index: 0机构: Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaKim, T. M.论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Canc Res Inst, Seoul, South Korea Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaYang, J-J.论文数: 0 引用数: 0 h-index: 0机构: Guangdong General Hosp, Guangdong Lung Canc Inst, Dept Oncol, Guangzhou, Peoples R China Guangdong Acad Med Sci, Guangzhou, Peoples R China Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaHuang, C.论文数: 0 引用数: 0 h-index: 0机构: Fujian Canc Hosp, Dept Thorac Oncol, Fujian, Peoples R China Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaVoon, P-J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Umum Sarawak, Sarawak, Malaysia Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaTho, L. M.论文数: 0 引用数: 0 h-index: 0机构: Pantai Hosp Kuala Lumpur, Dept Oncol, Kuala Lumpur, Malaysia Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaZhou, Q.论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Lung Canc Ctr, Chengdu, Sichuan, Peoples R China Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaWang, J.论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai, Peoples R China Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia论文数: 引用数: h-index:机构:Tan, D. S. W.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaDanchaivijitr, P.论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Fac Med, Dept Internal Med,Div Med Oncol, Bangkok, Thailand Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaNguyen, V. N.论文数: 0 引用数: 0 h-index: 0机构: Natl Lung Hosp, Hanoi, Vietnam Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaWong, K. H.论文数: 0 引用数: 0 h-index: 0机构: Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaYang, J. C-H.论文数: 0 引用数: 0 h-index: 0机构: Natl Taiwan Univ, Canc Ctr, Dept Med Oncol, Taipei, Taiwan Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaLe, X.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaEllers-Lenz, B.论文数: 0 引用数: 0 h-index: 0机构: Merck Healthcare KGaA, Dept Biostat, Darmstadt, Germany Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaKarachaliou, N.论文数: 0 引用数: 0 h-index: 0机构: Merck Healthcare KGaA, Global Clin Dev, Darmstadt, Germany Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaGhori, V.论文数: 0 引用数: 0 h-index: 0机构: Merck Healthcare KGaA, Global Patient Safety, Darmstadt, Germany Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaBerghoff, K.论文数: 0 引用数: 0 h-index: 0机构: Merck Healthcare KGaA, Global Patient Safety, Darmstadt, Germany Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, MalaysiaWu, Y-L.论文数: 0 引用数: 0 h-index: 0机构: Guangdong Acad Med Sci, Guangzhou, Peoples R China Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia
- [4] First line osimertinib for the treatment of patients with advanced EGFR-mutant NSCLC[J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S127 - S130论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:
- [5] Tepotinib plus Osimertinib for EGFR-Mutant NSCLC with Resistance to First-Line Osimertinib Due to MET amplification: INSIGHT 2[J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1099 - S1100Dooms, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Dept Resp Dis, Leuven, Belgium Univ Hosp Leuven, Resp Oncol Unit, Leuven, Belgium Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumNadal, E.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol, Sect Thorac Brain & Head & Neck Tumors, Dept Med Oncol, Barcelona, Spain Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumRaskin, J.论文数: 0 引用数: 0 h-index: 0机构: Antwerp Univ Hosp Uza, Dept Pulmonol & Thorac Oncol, Edegem, Belgium Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumDemedts, I.论文数: 0 引用数: 0 h-index: 0机构: Az Delta Hosp, Dept Pulm Dis, Roeselare, Belgium Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumMazieres, J.论文数: 0 引用数: 0 h-index: 0机构: CHU Toulouse, Inst Univ Canc, Toulouse, France Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumWislez, M.论文数: 0 引用数: 0 h-index: 0机构: Assistance Publ Hop Paris, Paris, France Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumAbdul, S.论文数: 0 引用数: 0 h-index: 0机构: Sarawak Gen Hosp, Dept Radiotherapy & Oncol, Kuching, Malaysia Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumMun, T. L.论文数: 0 引用数: 0 h-index: 0机构: Pantai Hosp Kuala Lumpur, Dept Oncol, Kuala Lumpur, Malaysia Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumWang, C.论文数: 0 引用数: 0 h-index: 0机构: Chang Gung Mem Hosp Kaohsiung, Kaohsiung, Taiwan Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumViteri, S.论文数: 0 引用数: 0 h-index: 0机构: Dexeus Univ Hosp, Quironsalud Grp, Dr Rosell Oncol Inst, Barcelona, Spain Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumLe, X.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumHow, S. H.论文数: 0 引用数: 0 h-index: 0机构: Hosp Tengku Ampuan Afzan, Pahang, Malaysia Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumTan, D.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Med Oncol Pharm, Singapore, Singapore Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumTakeda, M.论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Dept Med Oncol, Osaka, Japan Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumVeillon, R.论文数: 0 引用数: 0 h-index: 0机构: CHU Bordeaux, Serv Malad Resp, Bordeaux, France Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumKarachaliou, N.论文数: 0 引用数: 0 h-index: 0机构: Merck Kgaa, Global Clin Dev, Darmstadt, Germany Univ Hosp Leuven, Dept Resp Dis, Leuven, BelgiumEllers-Lenz, B.论文数: 0 引用数: 0 h-index: 0机构: Merck Kgaa, Dept Biostat, Darmstadt, Germany Univ Hosp Leuven, Dept Resp Dis, Leuven, Belgium论文数: 引用数: h-index:机构:Wu, Y.论文数: 0 引用数: 0 h-index: 0机构: Guangdong Prov PeopleS Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China Guangdong Acad Med Sci, Guangzhou, Peoples R China Univ Hosp Leuven, Dept Resp Dis, Leuven, Belgium
- [6] Treatment Patterns and Clinical Outcomes in Patients with EGFR-mutant NSCLC after Progression on First-Line Osimertinib[J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S364 - S364Robinson, N. D.论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, New Haven, CT USA Yale Sch Med, New Haven, CT USAZhan, P.论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, New Haven, CT USA Yale Sch Med, New Haven, CT USAUdelsman, B.论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, New Haven, CT USA Yale Sch Med, New Haven, CT USABoffa, D. J.论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, New Haven, CT USA Yale Sch Med, New Haven, CT USAGoldberg, S. B.论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, New Haven, CT USA Yale Sch Med, New Haven, CT USA
- [7] Assessment of early resistance mechanisms to first-line osimertinib in EGFR-mutant NSCLC using spatial transcriptomics[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1015 - S1016de Garibay, G. Ruiz论文数: 0 引用数: 0 h-index: 0机构: Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainRoch, B.论文数: 0 引用数: 0 h-index: 0机构: Hop Arnaud Villeneuve, Thorac Oncol Dept, Montpellier, France Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainGarrido Lopez, P.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Ramon Y Cajal, Dept Med Oncol, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainIsla, D.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Dept Med Oncol, Zaragoza, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainAguado, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ San Carlos, Dept Med Oncol, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainCallejo Perez, A.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Univ Hosp, Dept Oncol, Barcelona, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainMarse Fabregat, R.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Son Espases, Dept Oncol, Palma De Mallorca, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainGarcia Campelo, M. R.论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed A Coruna INIBIC, Dept Med Oncol, La Coruna, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainBlasco Cordellat, A.论文数: 0 引用数: 0 h-index: 0机构: CHGUV Consorcio Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainSanchez Torres, J. M.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ La Princesa, Med Oncol Dept, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainBernabe Caro, R.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainJuan Vidal, O. J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ & Politecn La Fe, Dept Med Oncol, Valencia, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainCarpeno, J. De Castro论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainFranco, F. F.论文数: 0 引用数: 0 h-index: 0机构: Hosp Puerta Hierro Majadahonda, Med Oncol, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainRamos Garcia, I.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Victoria, Serv Oncol Med, Malaga, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainGomez Rueda, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Ramon Y Cajal, Dept Oncol, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainConde Gallego, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Pathol, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainPonce Aix, S.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainPaz-Ares, L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Med Oncol Dept, Edificio Maternidad 2a Planta, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, SpainZugazagoitia, J.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain Hosp 12 Octubre i 12, Thorac & Clin Translat Oncol, Inst Invest Sanitaria, Madrid, Spain
- [8] Tepotinib plus osimertinib for EGFR-mutant NSCLC with resistance to first-line osimertinib due to MET amplification (METamp): INSIGHT 2[J]. ANNALS OF ONCOLOGY, 2021, 32 : S1036 - S1036Wu, Y-L.论文数: 0 引用数: 0 h-index: 0机构: Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China Guangdong Acad Med Sci, Guangzhou, Peoples R China Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaDooms, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Dept Resp Dis, Leuven, Belgium Univ Hosp Leuven, Resp Oncol Unit, Leuven, Belgium Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaNadal, E.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol, Dept Med Oncol, Barcelona, Spain Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaRaskin, J.论文数: 0 引用数: 0 h-index: 0机构: Antwerp Univ Hosp UZA, Dept Pulmonol & Thorac Oncol, Edegem, Belgium Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaDemedts, I.论文数: 0 引用数: 0 h-index: 0机构: AZ Delta Hosp, Dept Pulm Dis, Roeselare, Belgium Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaMazieres, J.论文数: 0 引用数: 0 h-index: 0机构: CHU Toulouse, Inst Univ Canc, Toulouse, France Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaWislez, M.论文数: 0 引用数: 0 h-index: 0机构: Assistance Publ Hop Paris, Paris, France Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaAbdul Shukor, S.论文数: 0 引用数: 0 h-index: 0机构: Sarawak Gen Hosp, Dept Radiotherapy & Oncol, Kuching, Malaysia Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaTho, L. M.论文数: 0 引用数: 0 h-index: 0机构: Pantai Hosp Kuala Lumpur, Dept Oncol, Kuala Lumpur, Malaysia Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaWang, C-C.论文数: 0 引用数: 0 h-index: 0机构: Chang Gung Mem Hosp Kaohsiung, Kaohsiung, Taiwan Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaViteri, S.论文数: 0 引用数: 0 h-index: 0机构: Dexeus Univ Hosp, Dr Rosell Oncol Inst, Quironsalud Grp, Barcelona, Spain Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaLe, X.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaHow, S. H.论文数: 0 引用数: 0 h-index: 0机构: Hosp Tengku Ampuan Afzan, Pahang, Malaysia Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaTan, D.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Med Oncol Pharm, Singapore, Singapore Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaTakeda, M.论文数: 0 引用数: 0 h-index: 0机构: Kindai Univ, Fac Med, Dept Med Oncol, Osaka, Japan Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaVeillon, R.论文数: 0 引用数: 0 h-index: 0机构: CHU Bordeaux, Serv Malad Resp, Bordeaux, France Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaKarachaliou, N.论文数: 0 引用数: 0 h-index: 0机构: Merck KGaA, Global Clin Dev, Darmstadt, Germany Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaEllers-Lenz, B.论文数: 0 引用数: 0 h-index: 0机构: Merck KGaA, Dept Biostat, Darmstadt, Germany Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R ChinaSmit, E. F. F.论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
- [9] Tepotinib plus osimertinib in EGFR-mutant NSCLC with MET amplification following first-line osimertinib: INSIGHT 2 primary analysis[J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)Le, Xiuning论文数: 0 引用数: 0 h-index: 0Kim, Tae Min论文数: 0 引用数: 0 h-index: 0Guarneri, Valentina论文数: 0 引用数: 0 h-index: 0Voon, Pei Jye论文数: 0 引用数: 0 h-index: 0Lim, Boon Khaw论文数: 0 引用数: 0 h-index: 0Yang, Jinji论文数: 0 引用数: 0 h-index: 0Wislez, Marie论文数: 0 引用数: 0 h-index: 0Huang, Cheng论文数: 0 引用数: 0 h-index: 0Liam, Chong Kim论文数: 0 引用数: 0 h-index: 0Mazieres, Julien论文数: 0 引用数: 0 h-index: 0Lye Mun Tho论文数: 0 引用数: 0 h-index: 0Hayashi, Hidetoshi论文数: 0 引用数: 0 h-index: 0Nguyen Nhung论文数: 0 引用数: 0 h-index: 0Chia, Puey Ling论文数: 0 引用数: 0 h-index: 0De Marinis, Fillippo论文数: 0 引用数: 0 h-index: 0Raskin, Jo论文数: 0 引用数: 0 h-index: 0Zhou, Qinghua论文数: 0 引用数: 0 h-index: 0Finochhiaro, Giovanna论文数: 0 引用数: 0 h-index: 0Tan, Daniel论文数: 0 引用数: 0 h-index: 0Brutlach, Sabine论文数: 0 引用数: 0 h-index: 0O'Brate, Aurora论文数: 0 引用数: 0 h-index: 0Adrian, Svenja论文数: 0 引用数: 0 h-index: 0Berghoff, Karin论文数: 0 引用数: 0 h-index: 0Ellers-Lenz, Barbara论文数: 0 引用数: 0 h-index: 0Karachaliou, Niki论文数: 0 引用数: 0 h-index: 0Wu, Yi-Long论文数: 0 引用数: 0 h-index: 0
- [10] The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib[J]. ONCOTARGETS AND THERAPY, 2023, 16 : 317 - 326Chen, Kuan-Chih论文数: 0 引用数: 0 h-index: 0机构: Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, TaiwanHuang, Yen-Hsiang论文数: 0 引用数: 0 h-index: 0机构: Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan Natl Yang Ming Chiao Tung Univ, Coll Med, Taipei, Taiwan Taichung Vet Gen Hosp, Lung Canc Comprehens Care & Res Ctr, Taichung, Taiwan Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, TaiwanHsu, Kuo-Hsuan论文数: 0 引用数: 0 h-index: 0机构: Taichung Vet Gen Hosp, Lung Canc Comprehens Care & Res Ctr, Taichung, Taiwan Taichung Vet Gen Hosp, Dept Internal Med, Div Crit Care & Resp Therapy, Taichung, Taiwan Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, TaiwanTseng, Jeng-Sen论文数: 0 引用数: 0 h-index: 0机构: Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan Natl Yang Ming Chiao Tung Univ, Coll Med, Taipei, Taiwan Taichung Vet Gen Hosp, Lung Canc Comprehens Care & Res Ctr, Taichung, Taiwan Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung, Taiwan Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, 1650,Sect 4,Taiwan Blvd, Taichung 407, Taiwan Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, TaiwanChang, Gee-Chen论文数: 0 引用数: 0 h-index: 0机构: Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan Chung Shan Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taichung, Taiwan Chung Shan Med Univ, Sch Med, Taichung, Taiwan Chung Shan Med Univ, Inst Med, Taichung, Taiwan Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan论文数: 引用数: h-index:机构: